ubenimex has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mathe, G | 1 |
| Oguro, M; Takagi, T; Takenaga, K; Yanagawa, T | 1 |
| Umezawa, H | 1 |
2 review(s) available for ubenimex and Leukemia L 1210
| Article | Year |
|---|---|
Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
Topics: Adjuvants, Immunologic; Animals; Aziridines; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Immunologic; Humans; Immunotherapy; Leucine; Leukemia L1210; Leukemia, Lymphoid; Levamisole; Lymphoma, Non-Hodgkin; Melanoma; Methotrexate; Mice; Neoplasms; Propionibacterium acnes; T-Lymphocytes, Regulatory; Thymosin | 1980 |
Low-molecular-weight immunomodifiers produced by micro-organisms.
Topics: Alkaline Phosphatase; Aminopeptidases; Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antibody Formation; Diaminopimelic Acid; Glycine; Guanidines; Hypersensitivity, Delayed; Immune Tolerance; Immunity; Immunity, Cellular; Lactones; Leucine; Leukemia L1210; Mice; Molecular Weight; Oligopeptides; Peptides; Polycyclic Sesquiterpenes; Sesquiterpenes; T-Lymphocytes, Regulatory | 1985 |
1 other study(ies) available for ubenimex and Leukemia L 1210
| Article | Year |
|---|---|
[Direct antitumor activity of biological response modifiers (B.R.M.) proven by an in vitro sensitivity test].
Topics: Animals; Biological Products; Cell Division; Cell Survival; Cell Wall; Cells, Cultured; Drug Resistance; Lentinan; Leucine; Leukemia L1210; Leukemia, Experimental; Mice; Nocardia; Picibanil; Polysaccharides; Proteoglycans | 1984 |